[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Thu, May 14th, 2026

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Thu, May 14th, 2026

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists

Marty Makary is resigning as President Donald Trump's Food and Drug Administration chief

Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes

Although a better-than-expected Q1 earnings print has NVAX stock skyrocketing recently, there’s a high risk in chasing this biotech play.

NVAX : 9.07 (-1.73%)
MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes

Moderna shares rally as investors bet on recent Hantavirus outbreak accelerating the biotech firm’s path to profitability. But there are ample reasons to avoid buying MRNA stock today.

MRNA : 50.51 (+0.18%)
OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a new entity

Biotech, Banks, and Bonds: Trading the Fed’s April Meeting

Late April Fed meeting may reset rate expectations. Biotech, financials, and long-duration Treasury ETF ideas for traders positioning both sides of Powell.

OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

OxyContin maker Purdue Pharma has been ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.